NTRS vs STRO · P/E 18, $32.02B cap vs rev $62.0M
Northern Trust Corporation (NTRS) versus Sutro Biopharma (STRO) — a side-by-side from cached financials, not a winner call.
Northern Trust Corporation (NTRS) is a asset management company listed on US.
Sutro Biopharma (STRO) is a biotechnology company listed on NASDAQ.
NTRS does not have a complete income-statement cache yet.
Latest reported STRO revenue for 2024-12-31 was $62.0M. Net income was -$227.5M. Revenue was down 59.6% from 2023-12-31 to 2024-12-31. STRO currently screens at market cap $470.8M.
NTRS currently screens at market cap $32.02B and trailing P/E 18.1. STRO currently screens at market cap $470.8M.
Not investment advice. Open the NTRS and STRO stock pages for the full models.
Not investment advice.